Testing a new weekly injection for sleep apnea and weight management

This study is testing a new medication called eloralintide, given as a weekly injection under the skin, to see if it can help people with obstructive sleep apnea (a condition where breathing stops and starts during sleep) who also struggle with their weight. The medication is being tested in two separate groups: people who cannot or do not want to use a CPAP machine, and people who are already using a CPAP machine. Researchers want to understand if this treatment can improve breathing, reduce sleep apnea symptoms, and support healthy weight loss.

Obstructive sleep apnea is a serious condition that affects millions of people, and the standard treatment (CPAP machines) doesn't work for everyone—either people can't tolerate it or choose not to use it. This medication is being studied because there's a need for additional treatment options that might address both the sleep apnea and the weight issues that often go together.